Clincosm LogoSign in Get a demo

Long-Covid in Patients Post Rehabilitation Treatment and Reintegration Into Everyday Life

Sponsor
Rehazentrum Walenstadtberg (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05755542
Collaborator
(none)
500
Enrollment
7.4
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The aim of the first study is to investigate how often a long Covid syndrome occurs after an inpatient rehabilitation due to previous hospitalization because of after acute Covid and whether there might be a connection with the severity during acute illness. 3 clusters of acute cases have been identified to be studied with regard to the long-term symptoms

  1. Mild course (medication, oxygen)

  2. Moderate course (IPS-IMC with NIV but without intubation)

  3. Severe course (intubation)

The aim of the second study is to use a catamnestic survey and subsequent evaluation of the information to gain an insight into the existing functional deficits relevant to everyday life and restriction of the ability to participate in the workplace after rehabilitation treatment. The assessment of functional deficits is carried out in relation to:

  1. Deficits in everyday skills (ADLs)

  2. Restrictions in the ability to participate in the profession.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    All patients who had been infected with Walenstadtberg after acute Covid infection were included.

    Patients were hospitalized for inpatient rehabilitation in the period from 01.04.2020 to 30.06.2022.

    A written follow-up survey was carried out with regard to a possible persistent long Covid symptoms and possible persistent deficits in everyday skills and Restrictions in the ability to participate in the profession. There are 2 cohort studies.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Occurrence of Long-Covid in Patients After Inpatient Rehabilitation Due to Acute Covid-19 Infection. How Easy is it for Patients to Return to Everyday Life and Work After Inpatient Rehabilitation Due to Acute Covid-19-infection?
    Anticipated Study Start Date :
    Mar 20, 2023
    Anticipated Primary Completion Date :
    Sep 1, 2023
    Anticipated Study Completion Date :
    Nov 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment [2 years]

      Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment

    2. Occurance of deficits in managing everyday life and work after covid infection [2 years]

      Investigation of deficits experienced by patients who have been treated at a rehabilitation facility after beeing hospitilized for a covid-19 infection and the impact of these deficits in everday life as well as in the workplace

    Secondary Outcome Measures

    1. reinfection with covid-19 after rehabilition treatment [2 years]

      reinfection with covid-19 after rehabilition treatment

    2. Impact of Covid-19 infection on quality of life [2 years]

      Impact of Covid-19 infection on quality of life in patients who have been treated at a rehabilition facility after beeing hospitilized due to a covid-19 infection

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • 18 years of age

    • treated at a rehabilitation facility after being hospitilized for covid-19 infection

    • complete questionnaire

    • written consent to use collected data

    Exclusion Criteria:

    • < 18 years

    • incomplete questionnaire

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Rehazentrum Walenstadtberg

    Investigators

    • Study Director: Stefan Bachman, Prof., Rehazentrum Walenstadtberg

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Rehazentrum Walenstadtberg
    ClinicalTrials.gov Identifier:
    NCT05755542
    Other Study ID Numbers:
    • Covid Outcome
    First Posted:
    Mar 6, 2023
    Last Update Posted:
    Mar 6, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Mar 6, 2023